Inventor · disambiguated record
Iwona Wrona
Also filed as: WRONA IWONA · WRONA IWONA E
10 granted patents·15 pending applications·13 citations·filing 2010–2025
82Inventor score
Files withJANSSEN PHARMACEUTICA NV11KINETA INC6YUMANITY THERAPEUTICS INC2BLACK DIAMOND THERAPEUTICS INC1DENG YONGQI1
Top patents by PatentIndex Score
25 records- 0192US12275723B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Apr 15, 2025·1 cites·16 claims
- 0286US11970486B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 30, 2024·3 cites·12 claims
- 0382US12180221B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 31, 2024·1 cites·20 claims
- 0480US2024300938A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0580US2025034125A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0680US2024400546A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0780US2025034124A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 0879US11873298B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jan 16, 2024·1 cites·8 claims
- 0977US2025304569A1Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2025·Application pending·0 cites
- 1075US8591943B2Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitorsDENG YONGQI·Filed 2010·Granted Nov 26, 2013·6 cites·2 claims
- 1169US10428072B2Inhibiting the transient receptor potential A1 ion channelLILLY CO ELI·Filed 2018·Granted Oct 1, 2019·1 cites·58 claims
- 1266US12098146B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Sep 24, 2024·0 cites·22 claims
- 1362US2025353851A1Purines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1460US2025288589A1Pyridopyrimidines and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1560US2025145642A1Bicyclic heteroarenes and methods of their useKINETA INC·Filed 2022·Application pending·0 cites
- 1655US9394308B2Inhibiting the transient receptor potential A1 ion channelMERCK SHARP & DOHME·Filed 2014·Granted Jul 19, 2016·0 cites·8 claims
- 1754US2024208964A1Pyridopyrimidines and methods of their usePYRIDOPYRIMIDINES AND METHODS OF THEIR USE·Filed 2021·Application pending·0 cites
- 1854US2024150358A1Purines and methods of their useKINETA INC·Filed 2021·Application pending·0 cites
- 1953US12268687B2Compounds and uses thereofJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 8, 2025·0 cites·29 claims
- 2053US2023271965A1Bicyclic heteroarenes and methods of their useKINETA INC·Filed 2021·Application pending·0 cites
- 2150US2024075042A1Method of treating cancers with alkyne substituted quinazoline derivativesBLACK DIAMOND THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2247US10919885B2Compounds and uses thereofYUMANITY THERAPEUTICS INC·Filed 2019·Granted Feb 16, 2021·0 cites·16 claims
- 2347US2023078764A1Compounds and uses thereofYUMANITY THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2439US2023339890A1Amino alcohol compounds and uses thereofKINETA INC·Filed 2021·Application pending·0 cites
- 2536US2017050966A1Inhibiting the transient receptor potential a1 ion channelHYDRA BIOSCIENCES INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Iwona Wrona files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →